BNET Industries
Last Fiscal Year Sales:$300.0M
- Private
- US
Dow Jones Description
At Banner, we work closely with our clients and scientists at pharmaceutical and consumer health care companies to develop the best solutions for formulation challenges and to help client lifecycle management challenges. We are committed to exceeding the expectations of our customers by providing quality products on time, and with exceptional service. Our Global Research and Development includes more than 14 PhDs from around the world with over 120 years of research experience in the field of drug delivery. That experience is coupled with state-of-the-art drug manufacturing facilities in High Point, North Carolina, U.S.; Tilburg, The Netherlands; Olds, Alberta, Canada; and Mexico City, Mexico.
President & Chief Executive Officer
Roger E. GordonNumber of Employees 500
Contact Information
4100 Mendenhall Oaks Pkwy
Suite 301
High Point, North Carolina 27265
(336) 812-3442
Peer Companies
NAICS Code Medicinal and Botanical Manufacturing: 325411
Recent Events
-
NPI Watch - Nov. 2, 2009 - Editorial: Dr. Joshua Sharfstein at the Annual...
News & Analysis
Filter by
banner pharmacaps inc. - All News and Analysis
Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules
- 2008-07-30
HIGH POINT, N.C. -- Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, today announced that the US Food & Drug Administration FDA has granted final approval for the Company's New Drug Application NDA for Valproic Acid Delayed Release soft gelatin...
Banner Pharmacaps Receives FDA Approval for Amantadine Softgel Capsules
- 2008-06-02
HIGH POINT, N.C. -- Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, announces that the US Food & Drug Administration granted approval for the Company's Abbreviated New Drug Application ANDA for Amantadine Hydrochloride USP 100 mg soft gelatin capsules on...
Banner Pharmacaps Receives FDA Approval for Nimodipine Softgel Capsules
- 2008-01-23
HIGH POINT, N.C. -- Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, today announced that the US Food & Drug Administration has granted approval for the Company's Abbreviated New Drug Application ANDA for Nimodipine 30 mg soft gelatin capsules. ...
Lannett Company Signs Supply Agreement with Banner Pharmacaps
- 2007-01-09
PHILADELPHIA -- Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced the signing of a supply agreement with Banner Pharmacaps, Inc. Under the terms of the agreement, Banner will supply Lannett with a certain pharmaceutical product, sales of which were approximately $54 million in 2005, for Lannett's...
Banner Pharmacaps, High Point, NC
- 2005-12-01
Banner Pharmacaps, High Point, NC, has been assigned U.S. Patent No. 6,949,256 for its development of a non-gelatin capsule shell formulation. The film-forming hydrocolloid composition uses kappa carrageenan, iota carrageenan, a bulking agent, plasticizer and water. The patent covers the methodology for making the capsules. Banner utilizes this technology in...
Banner Pharmacaps
- 2005-11-01
Banner Pharmacaps, Olds, Alberta, Canada, appointed Mark Hardison plant manager. Mr. Hardison has over 31 years of manufacturing experience and has been involved with the plant since 1998 when he first acted as a consultant. [ILLUSTRATION OMITTED]
Banner Soflet(R) Gelcaps Offer Increased Protection Against Drug Counterfeiting and Tampering.
- 2005-03-21
HIGH POINT, North Carolina, March 21 /PRNewswire/ -- Banner Pharmacaps SofletR Gelcaps can serve as a redundant safeguard with Radio Frequency Identification Devices RFID to help prevent counterfeiting of many susceptible tablet products. Soflet Gelcaps, a consumer-preferred dosage form, is a unique,...
Banner Pharmacaps
- 2004-07-01
Roger Gordon, president, Banner Pharmacaps, High Point, NC, has been appointed CEO of the company. Dr. Gordon joined Banner in 1999 as senior vice president of R & D. [ILLUSTRATION OMITTED]
Banner Pharmacaps has deployed XyLoc.(Partnerships and Deals)(Brief Article)
- 2004-05-01
Banner Pharmacaps has deployed XyLoc from Ensure Technologies to secure its manufacturing workstations.
Banner, CPC partner to launch ARTHx brand
- 2003-09-01
Banner Pharmacaps, High Point, NC, and Contract Pharmacal Corporation CPC, Hauppauge, NY, have formed a collaboration to begin the launch of CPC's recent acquisition of the ARTHx brand of joint support products using Banner's patented Soflet[R] Gelcap technology. Banner's Soflet Gelcap technology will be available in ARTHx Fast-Acting Glucosamine and...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Roger E. Gordon | President & Chief Executive Officer |
| Robert Gretton | CFO Banner |
| Aqeel Fatmi | Vice President, R & D, Operations |
| Charles Cain | Global VP of Legal and Human Resources |
| Robert S. Castellucci | Global Vice President, Quality, Systems and Compliance |
| Timothy B. Doran | Global Vice President, Commercial Operations |
| Organization | Position | Status |
|---|---|---|
| Banner Pharmacaps Inc. | President & Chief Executive Officer | Current |
| Pharmaceuticalsales.Com, Inc | Senior Vice President | Former |
| Pharmacia Corporation | Former | |
| Purdue University | Doctor of Philosophy, Industrial and Physical Pharmacy | Former |
| Organization | Position | Status |
|---|---|---|
| Banner Pharmacaps Inc. | CFO Banner | Current |
| Organization | Position | Status |
|---|---|---|
| Banner Pharmacaps Inc. | Vice President, R & D, Operations | Current |
| Co-Operations Inc | Global Vice President | Current |
| Georgia State University | Founder | Former |
| Solvay Pharmaceuticals, Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| Human Resources Incorporated | President, Legal | Current |
| Banner Pharmacaps Inc. | Global VP of Legal and Human Resources | Current |
| High Point Economic Development Corporation | Board Member | Current |
| High Point Chamber of Commerce | Board Member | Current |
| Banner Pharmacaps Inc. | Global Vice President of Legal and Human Resources | Former |
| The High Point | Partner | Former |
| The North Carolina Company | Partner | Former |
| Human Resources Incorporated | General Counsel | Former |
| Banner Pharmacaps Inc. | General Counsel | Former |
| Wake Forest University | B.A. In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Banner Pharmacaps Inc. | Global Vice President, Quality, Systems and Compliance | Current |
| Regulatory-Compliance.Com | Global Vice President, Quality Systems and Compliance | Current |
| Quality Control Corporation | Global Vice President, Quality Systems and Compliance | Current |
| Villanova University | M.S. Degrees In Biology | Former |
| Villanova University | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Banner Pharmacaps Inc. | Global Vice President, Commercial Operations | Current |
| Wake Forest University | Masters Degree in Business Administration | Former |
| Lynchburg College | BS degree in Business Administration and Communications | Former |
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
Glass Door
Banner Pharmacaps
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express